CS251210B1 - Bacteriologic nutrient medium prepared by means of sulhuric acids's protein hydrolysate - Google Patents
Bacteriologic nutrient medium prepared by means of sulhuric acids's protein hydrolysate Download PDFInfo
- Publication number
- CS251210B1 CS251210B1 CS172882A CS172882A CS251210B1 CS 251210 B1 CS251210 B1 CS 251210B1 CS 172882 A CS172882 A CS 172882A CS 172882 A CS172882 A CS 172882A CS 251210 B1 CS251210 B1 CS 251210B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- nutrient
- sulhuric
- bacteriologic
- acids
- sulfuric acid
- Prior art date
Links
- 235000015097 nutrients Nutrition 0.000 title claims 6
- 230000000721 bacterilogical effect Effects 0.000 title claims 3
- 239000003531 protein hydrolysate Substances 0.000 title claims 3
- 108010009736 Protein Hydrolysates Proteins 0.000 title claims 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 4
- 235000010633 broth Nutrition 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000001888 Peptone Substances 0.000 claims 1
- 108010080698 Peptones Proteins 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940041514 candida albicans extract Drugs 0.000 claims 1
- 239000005018 casein Substances 0.000 claims 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 1
- 235000021240 caseins Nutrition 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 229940025294 hemin Drugs 0.000 claims 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 238000011005 laboratory method Methods 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 235000019319 peptone Nutrition 0.000 claims 1
- 229940066779 peptones Drugs 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 239000002689 soil Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 239000003053 toxin Substances 0.000 claims 1
- 231100000765 toxin Toxicity 0.000 claims 1
- 108700012359 toxins Proteins 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 239000012138 yeast extract Substances 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 7
- 235000000421 Lepidium meyenii Nutrition 0.000 description 2
- 240000000759 Lepidium meyenii Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101100162168 Mus musculus Adam1a gene Proteins 0.000 description 2
- 101100322557 Rattus norvegicus Adam1 gene Proteins 0.000 description 2
- 235000012902 lepidium meyenii Nutrition 0.000 description 2
- KQPKMEYBZUPZGK-UHFFFAOYSA-N 4-[(4-azido-2-nitroanilino)methyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol Chemical compound CC1=NC=C(CO)C(CNC=2C(=CC(=CC=2)N=[N+]=[N-])[N+]([O-])=O)=C1O KQPKMEYBZUPZGK-UHFFFAOYSA-N 0.000 description 1
- 101150108431 CLDN4 gene Proteins 0.000 description 1
- 102100038447 Claudin-4 Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101001111984 Homo sapiens N-acylneuraminate-9-phosphatase Proteins 0.000 description 1
- 102100023906 N-acylneuraminate-9-phosphatase Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
-1-
EaKTepHcmorHqecKHe nHTaTeJiBWue cpeRbi c cepHOKHcnbtMH rHRponnaaTaMH CejiKa
aZ OCňaCTb ΠρΚΜβΗβΗΗΗ HaoOpeTeHHH
BaKTepHOJiOFHHecKHe πΗτβτβηΒΗΜβ cpeRbi c cepHOKHcnbíMH rHRponnsaTaMH Berne a Hcnont-3y»Tca wia BbipanmBaHHH BaxTepHň, fína o6meň H cneiptaJíhHoň CaKTepnónormiecKoňRHáPHOCTHKH, RJIH ÓHOXHMHqeCKHX aaRan, K8K HanpHMep, HSOJIHpOBaHHe nponyKTOB 06-Me«a BemecTB,H ftna HCcnenoBaHHft b 6aKTepnoJiornHecKoň γθηθτηκθ.
¢/ XapaKTepHCTHKa HSBecTHMX TexHHqecKHX pacTBopoB
HctiCkRbsyetede ro chx πορ πΗτβτβΠΒΗΜβ cpeflbí flnH BbipamHBaHHH ΒβκτβρΗή, rjih Brktc-pHonoFHMecKoň RHaFHocTHKH h fíjia HdonKpoBaHHfl SaKTepHanbHux tokchhob h aHTHre-HOB coRepxaT b ochqbhom BWcoKOMoneKynapHbie προτβΗΗΗ, xax HanpHMep, 3Η3Ημητη—necKH pacmenjieHHbie ΒβηκΗ /πθπτοηη/, nonyqeHHbie nyTen aBTOJiH3a RpoaoKeň šKCTpak-Tbl ΗΠΗ MHCHbie SKCTpaKTH ΗΠΗ MHCHbie ByjIbOHbl B KaneCTBe OCHOBHbIX ΠΗΤβΤβΠ&ΗΜΧ Be-meCTB. ílona HH3KOMOJieKyjiflpHbix nHTaTenbHbix BemecTB, τβκΗχ κβκ ημηηοκηοποτμ, bτηκηχ npoRyKTax asnaeTca oTHoCHTenbHo HH3Koň, τήκ πτο rjih OucTporo h xopomeropocTa OaxTepnň HeoOxoflHMo cooTBeTCTBywmee .ácáon&sÓBaaiie BHcoxoro KOJiHqecTfiaBcex πκτβτβηΒΗΜχ BemecTB. HáBeCTHo, hto BbicoKOMOJieKynapHbie προτβΗΗΗ h ÓanacT-Hbie BemecTBa, κΒκ ohh npHCyrcTByioT s nenTOHax, MoryT oxasusaTb ToKcnneoKoe bjih-ΛΗΗβ Ha SaxTepnH, c Rpyroň cropoHbí, τβκοβ OonBmoe KonHnecTBo BanacTHbix BemecTBBO3fleňCTByeT κηγη6ηρυ»π{ημ oBpasoM Ha poct CaKTepaň. ΙΪΒαπΗροΒβΗΗβ 6aKTepHanbHhixtokchhob H aHTHreHOB HcnbiTbiBaeT oTpHuaTenBHoe BOBAeňCTBHe, HanpHMep, sa cneT -Bbicoxoň ROJÍK O&naCTHblX BemecTB H ROJ1H BblCOKOMOJieKyJIHpHblX ΠρΟΤβΗΗΟΒ, EaKTepHO-norHHécKHe nHTaTejibHwe cpéRM rjih ηαβββηημχ oBnacTeň ηοποπβ3οβηηηη Η3Γοτββπηβ3-mtch Taxate nyreM RoBaBJíeHHH oTRenBHux ημηηοκηοποτ, orh3ko rjih BonbmHHCTBa 06-nacTefl πρΗΜβΗβΗΗΗ ohh b 3 τοή φορΜβ cjiHmxoM flopořu, HcnonbsyeMwe ro chx nop rrhaHanorHMHux neneň, nonyqeHHbie πγτβΜ conHHOKHcnoro rHRpojinsá rHRponnsaTbi 6ejixaconepaoT BCJieRCTBHe hx HšroTOBJíeHHH BonbniHe xonunecTBa NaCl, hto BOSReňcTByeT >na caRepxaHHe HHCna ηοηοβ ροτοβμχ ΠΗΤβτβΗΒΗκχ cpen, á τβκχβ oBycnaBjíHBaeT 60-nee BucoKoe coRepxaHHe οοτβτοηημχ nenTHROB, ΜβΜ πρκ cepHOKHCJioM PuRpánnae /thr-POJ1H3 ΠΟΑ RaBReHHeM/ nonýHeHHMX ΓΗΗρ0ΠΗ38Τ0Β. 251210 -2- / * C/ UejIH Η3θ6ρβΤβΗΗΗ OCHOBOft Η3θ6ρβΤβΗΗΗ HBHHeTCH 3aflana, HCnOJTb30BaTb nOJiyqeHHbie nyTeM CepHOKHCnO-ro rHflponn3a KaaeuHa ηπη flpyrnx HaTypanbHbix npoflyxTOB 6enxa γηαροπη33τμ 6&nxaηπη b hhctom BHne hjih K3K flo6aBKy κ nenTOHy, 3KCTpaxTy flpoataceň ηπη MHCHoMy. 6y-JiboHy KaK nHTaTenbHbie cpeflbí hjih noflxoflHtiiRe kom6hh3uhh πθπτοηθ c axcTpaKToMApoxaceň hjih aHanorHnHbie nHTaTenbHbie cpeflbí ηπη b κομ6ηη3αηη c BBipaxeHHbíMH noc-ΤβΒϋξΗΚβΜΗ 3ΗβρΓΗΗ, T3KHMH KaK ΓΠΚ)Κ038. ΤβΜ CaMblM ΗΟΠΟΠΒ3θΒ3ΗΗβ 9T.HX npoflyKTOB,coflepwamHx BbicoKOMoneKynHpHbie fianacTHbie BemecTBa Μοχετ 6μτβ 3HanHTenbHo GHHxe—HO H KaneCTBO ΠΗΤΗΤβΠΒΗΗΧ cpefl flHH Ha3BaHHblX oSnaCTeň HCnOJIb3OBaHHH MOHCeT 6bITbyjiynmeHo.
fl/ Κ3ΠΟΧ6ΗΗβ CyTH H3p6peTeHHH
Bbino ycTaHOBneHo, ητο 3Ta flenb Μοχβτ 6biTb flocTHrHyTa, ecjiH rHflponH3aTbi 6enKa,nonyweHHbie c noMombio cepHOKHcnoro rHflponH3a K336HHa hjíh flpyrHX ecTecTBeHHbixnponyKTOB 6βπκβ Hcnonb3OBaTb ηπη απη H36paHHbix rtpHMepoe πρΗΜεΗβΗΗΗ ηπη KaK flo-6aBKH Κ ΠΗΤβΤβΠΒΗΗΜ CpeflaM, Η3ΓΟΤΟΒΠβΗΗΜΜ B OCHOBHOM C BblCOKOMOneKynHpHblMH ΠΗ“TaTenbHWMH BemecTBaMH. ΠρΗ 3tom BO3HHKai0T TáKHe nHTaTenbHbie cpeflbí, κοτορΜβ co3HanMTenbHo noHHHeHHoň flonefí nHTaTenbHbix BemecTB flaioT απη 6aKTepHň noKaaaTennpocTa TaKHe xe ηπη 6onee nyqniHe, neM ro chx nop Hcnonb3yeMbie nHTaTenbHbie cpenu.C penyyHpoBaHHe KonHnecTBa 6anaCTHbix BemecTB b sthx πητητ&πβημχ cpeflax npoyeccwoGMena BemecTB MoryT 6ητβ nynme perynnpoBaHM, SaKTepHanbHbie npoflyKTbi οδΜβΗβ Be-mecTB MoryT 6biŤb nerne HaonHpoBaHbi. TaKHe' nHTaTenbHbie cpeflbí mh nonynaéM H3 kom-6HHaflHH CepHOKHCHblX ΓΗΑΡ0ΠΗ33Τ0Β ĎeflKa C ΓΠΚ)ΚΟ3θβ ΗΠΗ βΗβΠΟΓΗΠΗΟ ΗεΠΟΠΜΥβΜΗΜΗTHflpaTaMH yrnn, ΒΗΤ3ΜΗΗ3ΜΗ η ΜΗΚρΟΒΠΘΜβΗΤβΜΗ, C ΠβΠΤΟΗΟΜ, 3KCTpaKTOM flpOXXeft,MHCHblM 3KCTpaKT0M Η Τ.Π. IIpHMepbl ΒΗΠΟΠΗΘΗΗΗ 1-3 nOKa3b!BaK)T HeKOTOpbie TSKHe OC-HOBHbie nHTaTenbHbie cpeflbí, TačnHpa 1 φβκτορΗ pocTa απη OTflenbHbix bhaob ββκτβρκϋno cpaBHeHHio c Hcnonb3yeMbiMH no chx nop ňenTOHHbíMH πητβτθπβηημη cpenaMH. HaOCHOBe 3THX HOBblX OCHOBHbIX ΠΗΤβΤβΠΒΗΜΧ Cpefl MOXHO COCT3BHTb 6onbHIHHCTBO ΠΗΤβ-TenbHbix cpefl απη SaKTepnonornnecKoft αηαγηοοτηκη (nanp. ceneKTHBHbie nHTaTenbHbiecpeflbí, nHTaTenbHbie cpeflbí απη "necTporo pana", nHTaTenbHbie cpeflbí απη πη3οτοπηη),'flflH ĎHOXHMHneCKHX HCCneflOBaHHň H flflH SaKTepHanbHOň ΓβΗβΤΗΚΗ. ΠρΗΜβρ βμποπηθηηη4 ffaeT cocTaB ceneKTHBHoň nHTaTenbHoň cpeflbí, KOTopan Ha ocHOBe ee πηιπβ oneHbcna6wx ceneKTHBHbix cbořctb h MHoroo6pa3Hbix AHarHocTHnecKHx BO3MoxHocTeň onenbxopomo npHroflHa απη nepBOHananbHoň αηβγηοοτηκη ΗΗφβκιΐΗοΗΗΜχ BO36ýflHTeneft H3 mo-πη, nnmeBbix npoflyKTOB h flpyrnx MaTepnanoB HccneflOBaHHH, ΠρΗΜβρ HcnonHeHHH 5 fla-ετ cocTaB nHTaTenbHoň cpeflbí, npeflHa3HaneHHoň απη πηβοτοπηη Staphylococcus aure-us. Ha 9Toň nHTaTenbHoň cpefle μοχηο c 6onbmoň tobhoctbio onpenenHTb nH9Hc ΦαγοβΗ ΤβΜ CaMblM ΠΗ30ΤΗΠ. ΠρΗΜβρ HcnonHeHHH 6 noKa3biBaeT nHTaTenbHyio cpefly απη flOKaaaTenbCTBa η απη noný-neHHH reMonH3HHa H3 E. coli, κοτορβΗ Μοχβτ 6f>iTb CTaHflapTH3HpoBaHa no oTHomeHňio ‘κ Hcnonb3yeMHM flo chx nop mhchhm nHTaTenbHbíM 6ynboHaM. B πρΗΜβρβ βμποπηθηηη 7npHBefleaa nHTaTenbHan čpěna, npHroflHan απη npoH3BOflCTBa ΠΗ3θοτ8φΗΗ3 H3 PHK nrraM-Ma Staphylococcus aureus. npHBefleHHbie 3flecb πρΗΜβρω MoryT 6μτβ pacmHpeHbí no cMbicny. OcHOBHbie nHTaTenbHbiecpeflbí 1-3, a τβκχβ κομ6ηη8αηη c rnioKoaoň, βητημηηαμη h MHKposneMeHTaMH MoryT6μτβ, κβκ b cHCTeMe CTpoHTenbHbix aneMeHTOB, BBeneHbí b βηαθ πΗτβτεπΒΗΜΧ BemecTBb nHTaTenbHbie cpeflbí απη pa3nHHHeňBiHX o6nacTeň πρΗΜβΗβΗΗΗ (Hanp. Taxxe απη jipo-H3BOflCTB3 BaKflHHbl, npOH3BOflCTBa aHTHÓHOTHKOB) . 251210
-3- npHMep HCriOJIHeHHH 1
OcHOBHaa nHTaTejTbHag cpe^a ΠβπτοΗ1 3,0
CepHOKHCftbiň rHflpoftHaaT 6enKa 4,0 OKCTpaxT Apommeft2! 0,5-1,0
NaCl 5,0
Aqua dest. 1000 mji ήΠβπτοΗ Ká3eHHa naHKpeaTHgecKHň, CMemaHHWft πθπτοη (machoS, ρωβΗΜή h senaTHHo—Bblň ΠβΠΤΟΗ) , KpOBHHoň ΠΘΠΤΟΗ Η ΠΟΑθ6ΗΜβ.
^OKCTpaKT flpommeň "BpaMm" (TflP), skctpskt jxpowmeň na κορμοβηχ apojraceft (coBeT—ckhA npenapar), aBTonHaaT apommeň ΦΕΒ ΗμΦιπτοΦΦβθρκ fleccay, FflP ΠρΗΜβρ HCnOJIHeHHá 2 rnňpoJiH3áT eejiKa-3KCTpa«T apommeň-ocHoBHaH nHTaTenbHaH cpeaa r/n CepHOKHCJibiň γηπροπη3Ητ 6eaxa 4,0 3xcTpaKT apoxxeň "BpaMm’' 1,5 NaCl 5,0 Aqua dest. 1000 μπ ΠρΗΜβρ ΗΟΠΟΛΗβΗΗΗ 3 rHflpomreaT 6enKa-3KCTpaKT Apommeň-ocHOBHag rtHTaTejibHaa cpeaa CepHOKHcnbiň Γ«προπΗ3βτ Oejixa r/n 4,0 Okctpbkt ApoaoKeft "BpaMm" 1,0 MaČHoft aKCTpaKT3’ "χβΜβκε" (Μοηχθη, ΦΡΓ) 1,0 NaCl 5,0 Aqua dest. 1000 μπ *1 Μθ»βΤ 6blTb HCnonbSOBaH TBKM6 NWCHOň SKCTpaKT ΠΟ Πη6ηΓΥ ΗΠΗ MHCHoft GyjíbOH (roBHKHň, nomaanHbiň) κβκ pacTBopHTeab βμθθτο Aqua dest. IIpHMep HCnoJIHeHHH 5
IlHTaTejibHag cpeaa nna πηβοτηπηη οτθΦηποκοκκοβ r/n Πθπτοη H3 xaseHHa, naHKpeaTHnecKHň 4,0 CepHOKHCJibtft rnflponH3aT 6ejíKa 6,0 3KCTpaKT apommeň "BpaMm" 2,0 NaCl 5,0 Arap-arap 15,0 Ν3,00$ p.a. 0,32 Ιζ-τρΗΠΤΟφβΗ 0,064 Aqua dest. 1000 μπ 251210 -4- ΙΙρΗΜβρ HCnOJlHeHHH 4
Cpefla H3 Kpn3onffHHa noflacejiyfloqHoň »ene3bi h rJiHuepHHa (GCG) GCG-ocHOBaHHe
IlHTaTejibHbiň arap 11 (CHďHH) (coaepwnT 10 r nerrroHa 25 r naHKpeaTinecKoro, 10 r arapa nnn KynbTypaJibHbix cpefl, 5 r NaCl) Οκετρβκτ flpoacKeň (EpaMtn) 5 r cepHOKHCJibiň riwpoJiH3aT 6ejiKa (ΦΕΕ BepjiHH—XeMH) 2 r AMMOHHňHHft ιχΗτρβτ xejie3a-III 2 r
Na4S2035 H20 p.a. 3 r
KpH3OHAHH 40 ΜΓ roBHJKba noflwenyflOHHaH wejie3a (cymeHaa) 8 r
Aqua dest. 1 n
PaCTBOpHTb H CTepHJIH3OBaTb 2 qaca Ha βοηηηοΑ 6aHe, pH 7,3-7,5κ HeMy 29 mji GCG pacTBopa GCG-pacTBop ΓπΗίίβρκΗ 2. AB TflP 1 π STaHon 0,4 π
BpoMTHMOJIOBblň CHHHň 11,0 Γ
MoneBHHa p.a. 50,0 r npuMep HcnoJiHeHHH 6 nHTaTejibHafl cpe^a gna ROKasaTenbCTBa h pjin nanyqeHHg reMOJiH3HHa hs E, colí r/n
CepHOKHCHbiH rHflpo.nH3aT óejTKa 20,0
NaCl 5,0 rraoK03a 2. AB FflP 2,0
MacHoň 3KCTpaKT "χέΜβκε"31 20,0
Arap-arap 15,0
MgSO4·7 H40 p.a. 0,29
MnS04·4 H^O p.a. 0,014 ΑμμοηηΜημη uHTpaT 3Kejie3a-III 0,004 BHT3MHH B, 0,002 B6 0,002 ΑΜΗβ HHKOTHHOBOH KHCJIOTbl 0,002
Aqua. dest. 1000 μπ 31 Cm. cHocKy κ npuMepy HcnoJiFeHHg 3 251210 - 5 - ΠρΗΜβρ HCnOJIHgHHH 7
'ΠΗΤ8Τ6η&ΗβΗ cpepa fljifl npoH3BQ,qcTBa nH30TaýHHa H3 Tapn, aprep PUK r/n
IlHTaT&nbHMň CynbOH 1 (CEBAK, MCCP) c 5,0 r ΠβΠΤΟΗβ H 3,0; r MHCHoro 3HCTpaHTa/ň 8,0
CepHonucnMft rnpponHaaT Cenná 2,0
NaJKPQ,, · 2H40 p.a. 5,0
NaCl 1,0
Aqua dest. 1000 mji 3aABKa aa naTem-
BaKTepMonormieckue nHTaTenbHbie cpepbi c cepHonHcnbíM γηρροπηβρτομ Cenná oTJimia-toTca τβΜ, ητο nonyneHHbie c πομοπρ>κ> cepHonHcnoro rHpponH3a na3enHa ηπη ppyrnxecTecTBeHHbix npopynTOB Cenná γηρροπη3ρτβι Cenná csMOCTOHTenbHo ηπη b ηομ0ηηηρηηc npyrHMH paKWiMH 9Hepr.ii» nHTaTenbHbíMH BemecTBaMH, τβηημη nan πβπτοΗΜ, ancTpan-Tbi ppommeft, MacHbie ancrpanTK, rnronosa h nopoCHbie ncnonbayioT nan nHTaTenbHbieBemecTBa, n nonyneHHbíM TanHM oCpa3OM hobwm ochobhhm nHTaTenbHbíM cpepaM poCae-ηηιοτ HeoCxopuMbie pna pocra cnepHanH3HpoBaHHbix CanTepHň npnropHHe φβκτορΜ pocTaranné, nan HanpHMep, γθμηη, βητ8Μηημ, πθρητηη h nopoCHbie, Hcnonb3yror b cootho-πιθηηη n oCmenpHHBTWM po chx πορ πβπτοΗΗΜΜ nHTaTenbHbíM cpepaM Conee CepHbie 6a-nacTHbíMH BemecTBaMH nHTaTenbHbie cpepw e ποΜοηρ,ιο nopxopamero nopCopa cooTHome-hhh hohób H .ycnoBHň BbipauiHBaHHH nynbTypbi pna onTHManbHbix npopeccoB oCMeHa Be- .mecTB, nan HanpHMep, cnocoCHocTb oCpa3OBaHHa ToncHna ηπη HaCpaHHbie aapauH bCaKTepHajibHoft reHernne, a Taňme HapcTpaHBaa Ha τβηηχ ochobhhx cpepax Κ3γοτ8βπη*-Ba»T c noMoqhro npHťopňbix cenenTHBHbix poCapon, cyCcTpaTOB η ΗΗρκκβτοροΒ πΗτβ-Tenbuwe cpepbi pna CanTepHonorHqecnoň ρηργηοοτηκη ηπη cnepHanbHbix 3nnpeMnonorn-necHHx naCopdTopHbix ΜβτοροΒ h nonyqaioT nHTaTenbHbie cpepbi pna npoH3BopcTsa Ban-pHHbl H npOH3BOpCTBa 3ΗΤΗ6ΗΟΤΗΗΟΒ.
TaCnHpa 1: Φβητορω poCTa” HaCpaHHbix CanTepHanbHbix nrraMMOB npH pocre b
nHTaTenbHbix cpepax no npHMepy HcnonHeHHa 1, 2 h 3 b cooTHome-hhh n poCTy b nHrarenbHoň cpepe, copepmameň 20 r/n naHnpeaTH-qecnoro nenTona cnycTH 4 qaca h 8 qacoB
BanrepHanb“maň urraMM ΠρΗΜβρ HcnonHeHHa 1 ΠρΗΜβρ ηοποπηθηηη 2 ΠρΗΜβρ HcnonHeHHa 3 4 qaca 8 nacoB 4 qaca 8 nacoB 4 qaca 8 nacoB E. doli 54127 1,05 1,14 1,15 1,11 1,24 1,16 K, coli 350033 1,16 1,14 1,20 1,21 1,12 1,09 Pseudomonas Elsworth 1,17 1,08 1,21 1,01 1,27 1,07 Staph. aureus 1,16 1,22 1,50 1,13 1,58 . 1,08 78/71 ,251210 - 6 -
SaKTepnajib** ÍIpHMep HCnOJIHeHHH ' 1 IIpHMep McnoJiHeHtto ‘ IIpoflOJiMeHHe Ta6ji. 1 2 ΠρΗΜβρ HCnOJIHeHHH 3 Hbift dít a MM 1 4 Maca 8 Macos 4 «taca 8 Macoa 4 Maca 8 Macoa 1 Staph. aureus 1,20 1,26 .1,20 1,13 1,33 1,27 1413 1) Poct b κοΗτροπ&Ηοή πΗΤβτεπΒΗοή cpefle Φβκτορ pocTa pOCT B πΗτβτβΠΒΗοϋ cpefle c 20 γ/ji naHK- peaTswecKoro neirroHa
H3MepflI0TC« SHaneHHH 3KCTHHKflHH BCTpHXHBaeMblX KyJIbTypflO 37°C —*- v.
AHHOTaUHH
EaKTepHOJiorHMecKHe nHTaTejibHbie cpeflbí c cepHOKHCJibíMH rHflpojiH3aTaMH 6ejiKa.EaKTepHojiorHqecKHe nHTaTejibHbie cpeflbí c cepHOKHCjibíMH rHflpojiHaaTaMH 6ejixa ncnojib-3y»TCH flJin BHpamHBaHHH 6aKTepHňr fljur o6meň h cneflHajibHoň 6áKTepnoJiornMecKoňnuarHocTHKH, ftna 6ηοχημημθοκηχ 3aflan h ajih HccjieflOBaHHň b 6aKTepHojiorirqecKoňΓβΗβΤΗΚβ.
Hejibio Η3θ6ρβτβΗΗΗ h pemaeMoň hm aaflaneň hbjihiotch 6aKTepHonorHqecKHe nHTaTejihHbiecpeflbí c noHHxeHHbíM coflepacaHHeM fíanacTHbix BemecTB h BbicoKOMOJieKyjinpHbnc προτβπ-ΗΟΒ, KOTOpbie npH SKOHOMHqeCKH BbirOflHbIX yCJIOBHHX ΠΟ3ΒΟΠΗΙ0Τ nOJIHOCTbK) nOKpbITbnoTpe6neHne nHTaTenbHbix BenjecTB ČaKTepHHMH h Jiynme KOHTpoJiHpoBaTb 3φφεκτΗΒ**HOCTb OČMSHa BemeCTB.
EnaroflapH Hcnojib30BaHHio cepHOKHCJibix rHflpoJiH3aTOB 6enxa H3 Ka3eHHa hjih ποαο6ημχSejIKOBblX npOflyKTOB B MHCTOM BHfle HJIH B KOM6HHaflHH C rjHOKOSOň, BHTaMHHaMH Η MHK“poaJieMeHTaMH, hjih c πβπτοηβμη, 3κετρβκτοΜ apoxaceň hjih mhchmm ΒκςτρβκτοΜ, hjihKOM6HHauHeň sthx nHTaTejibHbix: BemecTB mojkho 3HauHTejibHo CHH3HT& coflepwaHHe 6a-jiacTHbix BemecTB b roTOBoň nHTaTejibHoň cpefle, nojiyneHHbie τβκημ nyTeM ocHoBHbienHTaTejihHbje cpeflbí mojkho HenocpeflCTBeHHo íuih B xawecTBe cocTaBHofí nacTH HcnoJib-3OBHTb B H3B6CTHbIX CeJieKTHBHblX IIHTaTejIbHblX CpeflaX, IIHTaTeJIbHblX cpeflax flJIH cne-flHaJIbHblX 3nHfleMHOJIOrHHeCKHX Jia6opaTOpHbIX MeTOflOB HJIH HJIH HayWHHX HCCJienoBaHHft.HcXOflH H3 3ΤΟΓΟ, T3KHé ΠΗΤβΤβΑΒΗΜβ cpeflbí flpHrOflHbl flJIH peineHHH ÓHOTeXHOJIOrHHec-•<hx npo6jieM, T3KHX kax, HanpHMep, npoHSBOflCTBO BaKflHHbí hjih θητηΘηοπικοβ. ΠρΗ3Η3Η0 Η3θ6ρβΤβΗΗβΜ ΠΟ pesyJIbTflTaM 3KCnepTH3bI, OCymeCTBJíeHHOft BeflOMCTBOMno fleJiaM Η3ο6ρβτβΗΗί1 η πβτβΗΤΟΒ TflP, 25121.0
Claims (1)
- - 7 - PfiBDMfiT VYNALEZU Bakteriologická živná půda s bílkovinným hydrolyzátem kyse-linou sírovou, vyznačující se tím, že bílkovinné hydrolyzátyzískané hydrolýzou kaseinu nebo jiných přírodních bílkovin-ných produktů kyselinou sírovou se samostatné nebo v kombi-naci s jinými energii poskytujícími živnými látkami, jakojsou peptony, kvasničný extrakt, masový extrakt, glukóza apodobně, používají jako živné látky, k takovýmto způsobemzískaným novým základním živným půdám se přidávají vhodnéfaktory růstu potřebné pro růst specializovaných bakterií,jako je například hemin, vitaminy, lecitin a podobně, při-čemž se využívají ve srovnání a dosud běžnými živnými půda-mi živné půdy s podstatně horšími balastními látkami pomocivhodné volby poměru iontů a podmínek pěstování kultur prooptimální proces látkové výměny, jako je například schop-nost vytvářet toxiny nebo pro vybrané úkoly v bakteriálnígenetice a také se s pomocí takových základních půd vyrábíza použití vhodných selektivních přísad, substrátů a indiká-torů živné půdy pro bakteriologickou diagnostiku nebo speci-elní epidemiologické laboratorní metody a získávají.se živ-né půdy pro výrobu vakcin a antibiotik. Uzgorodský výrobně-polygrafjtiký podnik, Proektnaja 4, UzgorodIP 1824 , Cena 2,40 Kcs 251210
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD23005481A DD159844A3 (de) | 1981-05-19 | 1981-05-19 | Bakteriologische naehrmedien mit schwefelsauren eiweisshydrolysaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS251210B1 true CS251210B1 (en) | 1987-06-11 |
Family
ID=5530985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS172882A CS251210B1 (en) | 1981-05-19 | 1982-03-12 | Bacteriologic nutrient medium prepared by means of sulhuric acids's protein hydrolysate |
Country Status (4)
| Country | Link |
|---|---|
| CS (1) | CS251210B1 (cs) |
| DD (1) | DD159844A3 (cs) |
| DE (1) | DE3212673A1 (cs) |
| GB (1) | GB2099454B (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60234597A (ja) * | 1984-05-09 | 1985-11-21 | Terumo Corp | β−ガラクトシダ−ゼ試験用培地 |
| FR2613728B1 (fr) * | 1987-04-10 | 1990-12-21 | Cortial | Milieu pour isoler et identifier les candida |
-
1981
- 1981-05-19 DD DD23005481A patent/DD159844A3/de not_active IP Right Cessation
-
1982
- 1982-03-12 CS CS172882A patent/CS251210B1/cs unknown
- 1982-04-05 DE DE19823212673 patent/DE3212673A1/de not_active Withdrawn
- 1982-05-11 GB GB8213614A patent/GB2099454B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2099454B (en) | 1984-09-12 |
| DD159844A3 (de) | 1983-04-13 |
| GB2099454A (en) | 1982-12-08 |
| DE3212673A1 (de) | 1984-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2595499A (en) | Process for production of vitamin b12 | |
| GB1370892A (en) | Microbiological production of protein | |
| AU6970187A (en) | Metal ion labeling of carrier molecules | |
| IE44904L (en) | Aminophosphorous acids. | |
| Hahn et al. | MODE OF ACTION OF CHLORAMPHENICOL II: Inhibition of Bacterial d-Polypeptide Formation by an l-Stereoisomer of Chloramphenicol | |
| GB1467303A (en) | Production of zeaxanthin | |
| Dunn | Determination of amino acids by microbiological assay | |
| US3865693A (en) | Process for the production of antibiotic substance cephemimycin | |
| CS251210B1 (en) | Bacteriologic nutrient medium prepared by means of sulhuric acids's protein hydrolysate | |
| Sadoff et al. | Properties of fructose 1, 6-diphosphate aldolases from spores and vegetative cells of Bacillus cereus | |
| Mok et al. | The carbon monoxide-reactive haemoproteins of yeast | |
| Porter et al. | The nutrition of Staphylococcus aureus: The influence of biotin, bios IIB and vitamin H on the growth of several strains | |
| Gill | CULTURE AND METABOLISM OF MYCOPLASMA GLLISEPTICUM | |
| JPS59135886A (ja) | ビリルビン・オキシダ−ゼの製造法 | |
| JPS6029473B2 (ja) | ザルコシン・オキシダ−ゼの製法 | |
| Yoshinaga et al. | Production of amino acids. | |
| CA1050461A (en) | Antitumor antibiotic macracidmycin from streptomyces atrofaciens | |
| GB1324159A (en) | Process for producing 7-amino desacetoxy cephalosporanic acid | |
| Levy et al. | Bacterial Peptidases: II. ENZYMES SPECIFIC FOR N-ACYL LINKAGES TO ASPARTATE | |
| US3562110A (en) | Production of amino acids | |
| US3694316A (en) | Process for preparing protease by microorganism of the basidiomycetes | |
| Yamasaki et al. | A simple colorimetric method for the determination of lysozyme activity | |
| JPS59198982A (ja) | 新抗生物質ｓｆ−２２４０物質およびその製造法 | |
| US3997397A (en) | Production of proteic materials from yeast cells | |
| US4221705A (en) | Novel peptide type antibiotic and the process for the production thereof |